免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

AccuContour 4.0

K号: K251351 · 2026-01-23

决定日期2026-01-23
产品代码QKB
咨询委员会RA
决定实质等同

器械摘要

AccuContour 4.0 is the device name listed in this FDA 510(k) record. The listed applicant is Manteia Technologies Co., Ltd.. It received FDA 510(k) clearance on 2026-01-23 under 510(k) number K251351. The device is classified under product code QKB. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the AccuContour 4.0?

AccuContour 4.0 is a medical device that received FDA 510(k) clearance on 2026-01-23. The listed applicant is Manteia Technologies Co., Ltd.. The 510(k) number is K251351.

When did AccuContour 4.0 receive FDA 510(k) clearance?

AccuContour 4.0 received FDA 510(k) clearance on 2026-01-23, under 510(k) number K251351.

Who is the listed applicant for AccuContour 4.0?

FDA 510(k)记录将Manteia Technologies Co., Ltd.列为申请人。这本身并不足以确立该设备制造商的身份。

What is the FDA product code for AccuContour 4.0?

The FDA product code for AccuContour 4.0 is QKB.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Manteia Technologies Co., Ltd.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 7 个设备 →

相关器械(代码:QKB)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑